IP Library Patent Application 16534711
Patent Application
App. No. 16/534,711

COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/534,711
Abstract

The present invention provides a process for the preparation of a stable and homogeneous liquid composition that is suitable for enteral administration comprising a digestive enzyme product and nutrients from a nutritional formula having specific amount of nutrients. The invention further provides a method for efficiently and effectively administering a therapeutically effective dose of the stable and homogeneous liquid composition by means of an enteral tube.

Claims (17)

1 ) A process for the preparation of a stable and homogeneous liquid composition that is suitable for enteral administration comprising a digestive enzyme product and nutrients from a nutritional formula, said process comprising the following steps:

a) preparing a suspension of digestive enzymes in aqueous solution comprising the step of:

a.1) reducing the size of the digestive enzyme product;

a.2) adding an aqueous solution;

a.3) mixing to form the suspension; and

a.4) keeping it for a period of time greater than about 5 minutes; and

b) mixing the suspension with a liquid nutritional formula to form the stable and homogeneous liquid composition;

wherein the nutritional formula has a total fat and protein and carbohydrate nutrient content from about 10 to about 35 g/100 mL, or has a total fat and protein nutrient content from about 4.5 to about 11.5 g/100 mL, or has a total fat nutrient content from about 3.0 to about 7.0 g/100 mL, or has a total protein nutrient content from about 1.3 to about 6.3 g/100 mL,

wherein the aqueous solution of step a.2) is selected from the list consisting of:

purified water; deionized water; sterile water; tap water; and physiological saline solution, and wherein the aqueous solution of step a.2) is added in an amount of less than 10 mL.

2 ) The process of claim 1 , wherein the period of time of step a.4) is between about 15 and about 30 minutes.

3 ) The process of claim 1 , wherein the aqueous solution of step a.2) is added in amount of about 2.5 mL for a digestive enzyme product having about 10,400 USP units of lipase, or a corresponding multiple amount of solution is added for a product having multiple USP units of lipase.

4 ) The process of claim 1 , wherein the digestive enzyme product is a non-gastroresistant product.

5 ) The process of claim 1 , wherein the digestive enzyme product is either uncoated or coated.

6 ) The process of claim 1 , wherein the pancrelipase enzyme product is in the form of powder, granules, tablets, spheres, minitablets, microtablets, microparticles, microspheres, microcapsules or micropellets and/or

wherein the pancrelipase enzyme product is an immediate release pancrelipase enzymes product or dosage form.

7 ) The process of claim 1 , wherein the nutritional formula is adult/child formula or infant formula.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: PIRONTI, VINCENZA; RONDA, EMANUELA; BOLTRI, LUIGI
To: APTALIS PHARMA S.R.L.
Reel/Frame 049993/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: APTALIS PHARMA S.R.L.
To: APTALIS PHARMA LIMITED
Reel/Frame 049993/0827 →
CHANGE OF NAME Recorded Aug 7, 2019
From: APTALIS PHARMA LIMITED
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 049994/0095 →